| Original language | English |
|---|---|
| Pages (from-to) | 1351-1366 |
| Journal | EMBO Molecular Medicine |
| Volume | 5 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published (in print/issue) - 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- acute myeloid leukaemia
- antibody therapy
- FLT3-ITD mutation
- PRL-3
- prognostic marker
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver